$CL

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

Original reporting
Published Nov 2, 2026, 10:08 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:22 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CL
Bullish
high confidence
Mentioned
$CL
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CLBullishMed
01

Why it matters

Analyst price‑target upgrades and earnings beat provide a fresh catalyst for the stock.

02

Market read

The earnings beat and target raise constitute primary company news that can drive short‑term price movement.

03

What to watch

Potential headwinds from tariffs and logistics challenges could limit upside.

Relevance 7/10Novelty 7/10Timing: today

Background

Colgate-Palmolive reported Q3 2026 earnings of $0.97 EPS, beating consensus, and raised its fiscal outlook.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

BofA raised its price target on Colgate-Palmolive to $105 after the company posted earnings that beat estimates.

Expected impact

likely upward pressure as investors price in the higher target and earnings beat

Evidence & confidence

Analyst target increase and better‑than‑expected EPS are fresh, material information that can move the share price.

Market effects

Consumer staples may see modest uplift as a major player reports stronger margins.

North American consumer‑goods stocks could benefit from the earnings beat.

Emerging‑market exposure in Colgate's growth story adds a global tilt to the positive sentiment.

Counterpoint

If cost pressures persist, the raised target may be overly optimistic.

Key entities

  • Colgate-Palmolive Company

    Consumer‑goods manufacturer reporting earnings beat and higher price target.

  • BofA Securities

    Raised price target to $105, indicating bullish outlook.

Related articles

$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.